Antibiotic retreatment of Lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials

Antibiotic retreatment of Lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials Allison K. DeLong, Barbara Blossom, Elizabeth Maloney, Steven E. Phillips Abstract Introduction Lyme disease (Lyme borreliosis) is caused by the tick-borne spirochete Borrelia burgdorferi. Long-term persistent illness following antibiotic treatment is not uncommon, particularly when treatment is […]

Seal_of_the_United_States_Congress

US Congressional Hearing on Lyme Disease

Video streaming by Ustream This meeting took place in the US House of Representatives on July 17, 2012. [Please scroll ahead, hearing begins at minute 28:00 of the video.] Subcommittee on Africa, Global Health, and Human Rights Chaired by Christopher H. Smith (R-NJ) Witnesses from the IDSA, CDC and NIH were invited to the hearing […]

IDSA_Facebook_flap

Response to the IDSA Facebook post

On January 4, 2012, when the IDSA posted the question on their Facebook page, “What would you like to see from your society in the coming year?” the sheer volume of earnest and desperate comments from Lyme Disease sufferers became a phenomenon. The comments are still coming in. This document captures the 2,350 comments that […]

“Single-Dose Doxy” for prevention is not supported by science or common sense

Here’s the link to Dr Elizabeth Maloney’s paper, “Challenge to the Recommendation on the Prophylaxis of Lyme Disease” (PDF). The “Prophylaxis Recommendation” of the IDSA Guidelines — Recommendation #2 — is poorly supported by its only supporting literature. Moreover, the “Single-Dose Doxy” practise is difficult to implement in a clinical setting; and furthermore, it is, in […]